CABRINI, Giulio
 Distribuzione geografica
Continente #
EU - Europa 4.386
NA - Nord America 1.863
AS - Asia 1.294
SA - Sud America 223
AF - Africa 27
OC - Oceania 1
Totale 7.794
Nazione #
FI - Finlandia 3.759
US - Stati Uniti d'America 1.803
SG - Singapore 445
CN - Cina 284
IT - Italia 234
VN - Vietnam 187
BR - Brasile 171
HK - Hong Kong 124
DE - Germania 92
PL - Polonia 58
GB - Regno Unito 49
ID - Indonesia 46
JP - Giappone 43
TR - Turchia 42
SE - Svezia 39
FR - Francia 35
CA - Canada 30
RU - Federazione Russa 29
UA - Ucraina 29
IN - India 27
MX - Messico 24
NL - Olanda 21
AR - Argentina 19
TH - Thailandia 16
IQ - Iraq 15
BD - Bangladesh 13
PH - Filippine 10
UZ - Uzbekistan 10
ES - Italia 9
ZA - Sudafrica 9
CO - Colombia 8
MY - Malesia 7
VE - Venezuela 6
BE - Belgio 5
EC - Ecuador 5
PK - Pakistan 5
SA - Arabia Saudita 5
CL - Cile 4
MA - Marocco 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IE - Irlanda 3
JO - Giordania 3
LT - Lituania 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AT - Austria 2
DZ - Algeria 2
IR - Iran 2
KR - Corea 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MG - Madagascar 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.794
Città #
Helsinki 3.735
Singapore 301
Ashburn 283
San Jose 148
Fairfield 126
Hong Kong 123
Beijing 114
Woodbridge 110
Ferrara 99
Santa Clara 95
Los Angeles 77
Chandler 73
Houston 65
Ho Chi Minh City 63
Dallas 56
Warsaw 56
Wilmington 48
Cambridge 46
Seattle 45
Munich 44
Tokyo 43
Jakarta 41
Hanoi 38
Ann Arbor 32
Jacksonville 30
New York 29
Shanghai 25
Lauterbourg 23
Council Bluffs 22
São Paulo 22
Buffalo 20
Izmir 19
Addison 18
Princeton 17
Turku 17
Bangkok 15
Milan 15
Brooklyn 14
Atlanta 13
Mexico City 13
Chicago 12
London 11
Nanjing 11
Toronto 11
Washington 11
Bologna 10
Chennai 10
Denver 10
Frankfurt am Main 10
Boardman 9
Montreal 9
Orem 9
Tashkent 9
Ankara 8
Bremen 8
Poplar 8
Rio de Janeiro 8
Shenyang 8
Dong Ket 7
Stockholm 7
Da Nang 6
Kuala Selangor 6
Moscow 6
Nuremberg 6
Padova 6
Querétaro 6
San Diego 6
The Dalles 6
Tianjin 6
Amsterdam 5
Baghdad 5
Biên Hòa 5
Haiphong 5
Hebei 5
Hefei 5
Mountain View 5
Assago 4
Boston 4
Brasília 4
Changsha 4
Dearborn 4
Dhaka 4
Ferrara di Monte Baldo 4
Jiaxing 4
Johannesburg 4
Manchester 4
Manila 4
Nanchang 4
Phoenix 4
San Francisco 4
Vũng Tàu 4
Bogotá 3
Brussels 3
Burlingame 3
Bắc Ninh 3
Bến Tre 3
Campinas 3
Can Tho 3
Cape Town 3
Cesena 3
Totale 6.535
Nome #
A new method for measuring local ATP release at the extracellular surface of live intact cells 2.073
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.012
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 268
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 243
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 232
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 232
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 231
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 225
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 184
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 171
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 168
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib 167
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 162
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 153
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis 148
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 140
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 132
Mitochondrial Ca2+-dependent inflammasome activation exacerbates the P. aeruginosa-driven inflammatory response 132
miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases 120
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 111
CFTR Modulators and Reduction of Airway Inflammation in Cystic Fibrosis: How Much is Enough? 94
Overview of CF lung pathophysiology 91
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis 83
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients 82
Revealing the microRNA-transcription factors network in cystic fibrosis:from microRNA therapeutics to precision medicine (CF-miRNA-THER) FFC 7/2018 79
GY971, a new anti-inflammatory agent for the treatment of Cystic Fibrosis lung disease 45
Evaluation of hyaluronic acid derivates as new anti-inflammatory treatments for cystic fibrosis 42
Hyaluronic acid derivates as new potential anti-inflammatory agents for Cystic Fibrosis lung disease 35
Pre-clinical validation of GY971, a new anti-inflammatory agent targeting Nuclear Factor kappa B (NF-kB) 24
Totale 7.879
Categoria #
all - tutte 23.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021106 0 0 0 0 0 0 0 0 0 40 34 32
2021/2022191 9 8 18 6 9 8 21 13 13 12 25 49
2022/2023191 21 34 4 19 22 14 25 10 16 1 14 11
2023/2024260 13 20 16 3 64 45 9 21 4 3 6 56
2024/2025731 23 29 74 52 75 52 26 39 96 62 102 101
2025/20265.701 204 67 150 220 311 192 293 117 3.954 193 0 0
Totale 7.879